Cyanogenic Glycoside Content of Fresh and Processed Peels of Four Improved Ghanaian Cassava Cultivars

Autor: Adamafio, NA, Ankrah, NA, Aryee, KE

Publikováno v: Ghana Journal of Science; Vol 49 (2009); 57-63

The cyanogenic glycoside levels of four relatively new Ghanaian cassava cultivars were determined spectrophotometrically. The mean values obtained were 393.8, 548.9, 702.1 and 424.7 p.p.m. for Afisiafi, Abasafitaa, IITA9904 and Tech Bankye, respectiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::c24eae6c353beedf82890b5e6addb88d
https://www.ajol.info/index.php/gjs/article/view/77591

Enhanced development of functional human NK cells in NOD-scid-IL2rg ^null mice expressing human IL15.

Autor: Aryee KE; Program in Molecular Medicine, Diabetes Center of Excellence, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA., Burzenski LM; The Jackson Laboratory, Bar Harbor, Massachusetts, USA., Yao LC; The Jackson Laboratory, Sacramento, California, USA., Keck JG; The Jackson Laboratory, Sacramento, California, USA., Greiner DL; Program in Molecular Medicine, Diabetes Center of Excellence, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA., Shultz LD; The Jackson Laboratory, Bar Harbor, Massachusetts, USA., Brehm MA; Program in Molecular Medicine, Diabetes Center of Excellence, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Publikováno v: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2022 Sep; Vol. 36 (9), pp. e22476.

Gene Therapy with an Adeno-Associated Viral Vector Expressing Human Interleukin-2 Alters Immune System Homeostasis in Humanized Mice.

Autor: Durost PA; 1 Program in Molecular Medicine, University of Massachusetts Medical School , Worcester, Massachusetts., Aryee KE; 1 Program in Molecular Medicine, University of Massachusetts Medical School , Worcester, Massachusetts., Manzoor F; 2 Department of Immunology and Microbiology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina., Tisch RM; 2 Department of Immunology and Microbiology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina., Mueller C; 3 Department of Pediatrics and Horae Gene Therapy Center, University of Massachusetts Medical School , Worcester, Massachusetts., Jurczyk A; 1 Program in Molecular Medicine, University of Massachusetts Medical School , Worcester, Massachusetts., Shultz LD; 4 Jackson Laboratory , Bar Harbor, Maine., Brehm MA; 1 Program in Molecular Medicine, University of Massachusetts Medical School , Worcester, Massachusetts.

Publikováno v: Human gene therapy [Hum Gene Ther] 2018 Mar; Vol. 29 (3), pp. 352-365. Date of Electronic Publication: 2017 Oct 03.

Humanized Mouse Models of Clinical Disease.

Autor: Walsh NC; Department of Molecular Medicine, Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, Massachusetts 01605., Kenney LL; Department of Molecular Medicine, Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, Massachusetts 01605., Jangalwe S; Department of Molecular Medicine, Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, Massachusetts 01605., Aryee KE; Department of Molecular Medicine, Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, Massachusetts 01605., Greiner DL; Department of Molecular Medicine, Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, Massachusetts 01605., Brehm MA; Department of Molecular Medicine, Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, Massachusetts 01605., Shultz LD; The Jackson Laboratory, Bar Harbor, Maine 04609; email: lenny.shultz@jax.org.

Publikováno v: Annual review of pathology [Annu Rev Pathol] 2017 Jan 24; Vol. 12, pp. 187-215. Date of Electronic Publication: 2016 Dec 05.

Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic β-cell function via glycogen synthase kinase-3β.

Autor: Jurczyk A; Diabetes Center of Excellence, Program in Molecular Medicine, and Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, Massachusetts, USA; Department of Public Health, University of Massachusetts, Amherst, Massachusetts, USA; Department of Pathology, University of Florida, Gainesville, Florida, USA; and The Jackson Laboratory; Bar Harbor, Maine, USA., Nowosielska A; Diabetes Center of Excellence, Program in Molecular Medicine, and Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, Massachusetts, USA; Department of Public Health, University of Massachusetts, Amherst, Massachusetts, USA; Department of Pathology, University of Florida, Gainesville, Florida, USA; and The Jackson Laboratory; Bar Harbor, Maine, USA., Przewozniak N; Diabetes Center of Excellence, Program in Molecular Medicine, and Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, Massachusetts, USA; Department of Public Health, University of Massachusetts, Amherst, Massachusetts, USA; Department of Pathology, University of Florida, Gainesville, Florida, USA; and The Jackson Laboratory; Bar Harbor, Maine, USA., Aryee KE; Diabetes Center of Excellence, Program in Molecular Medicine, and Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, Massachusetts, USA; Department of Public Health, University of Massachusetts, Amherst, Massachusetts, USA; Department of Pathology, University of Florida, Gainesville, Florida, USA; and The Jackson Laboratory; Bar Harbor, Maine, USA., DiIorio P; Diabetes Center of Excellence, Program in Molecular Medicine, and Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, Massachusetts, USA; Department of Public Health, University of Massachusetts, Amherst, Massachusetts, USA; Department of Pathology, University of Florida, Gainesville, Florida, USA; and The Jackson Laboratory; Bar Harbor, Maine, USA., Blodgett D; Diabetes Center of Excellence, Program in Molecular Medicine, and Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, Massachusetts, USA; Department of Public Health, University of Massachusetts, Amherst, Massachusetts, USA; Department of Pathology, University of Florida, Gainesville, Florida, USA; and The Jackson Laboratory; Bar Harbor, Maine, USA., Yang C; Diabetes Center of Excellence, Program in Molecular Medicine, and Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, Massachusetts, USA; Department of Public Health, University of Massachusetts, Amherst, Massachusetts, USA; Department of Pathology, University of Florida, Gainesville, Florida, USA; and The Jackson Laboratory; Bar Harbor, Maine, USA., Campbell-Thompson M; Diabetes Center of Excellence, Program in Molecular Medicine, and Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, Massachusetts, USA; Department of Public Health, University of Massachusetts, Amherst, Massachusetts, USA; Department of Pathology, University of Florida, Gainesville, Florida, USA; and The Jackson Laboratory; Bar Harbor, Maine, USA., Atkinson M; Diabetes Center of Excellence, Program in Molecular Medicine, and Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, Massachusetts, USA; Department of Public Health, University of Massachusetts, Amherst, Massachusetts, USA; Department of Pathology, University of Florida, Gainesville, Florida, USA; and The Jackson Laboratory; Bar Harbor, Maine, USA., Shultz L; Diabetes Center of Excellence, Program in Molecular Medicine, and Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, Massachusetts, USA; Department of Public Health, University of Massachusetts, Amherst, Massachusetts, USA; Department of Pathology, University of Florida, Gainesville, Florida, USA; and The Jackson Laboratory; Bar Harbor, Maine, USA., Rittenhouse A; Diabetes Center of Excellence, Program in Molecular Medicine, and Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, Massachusetts, USA; Department of Public Health, University of Massachusetts, Amherst, Massachusetts, USA; Department of Pathology, University of Florida, Gainesville, Florida, USA; and The Jackson Laboratory; Bar Harbor, Maine, USA., Harlan D; Diabetes Center of Excellence, Program in Molecular Medicine, and Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, Massachusetts, USA; Department of Public Health, University of Massachusetts, Amherst, Massachusetts, USA; Department of Pathology, University of Florida, Gainesville, Florida, USA; and The Jackson Laboratory; Bar Harbor, Maine, USA., Greiner D; Diabetes Center of Excellence, Program in Molecular Medicine, and Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, Massachusetts, USA; Department of Public Health, University of Massachusetts, Amherst, Massachusetts, USA; Department of Pathology, University of Florida, Gainesville, Florida, USA; and The Jackson Laboratory; Bar Harbor, Maine, USA., Bortell R; Diabetes Center of Excellence, Program in Molecular Medicine, and Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, Massachusetts, USA; Department of Public Health, University of Massachusetts, Amherst, Massachusetts, USA; Department of Pathology, University of Florida, Gainesville, Florida, USA; and The Jackson Laboratory; Bar Harbor, Maine, USA rita.bortell@umassmed.edu.

Publikováno v: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2016 Feb; Vol. 30 (2), pp. 983-93. Date of Electronic Publication: 2015 Nov 06.